Related Experiment Video
Updated: May 8, 2026

Spatio-Temporal Manipulation of Small GTPase Activity at Subcellular Level and on Timescale of Seconds in Living Cells
Published on: March 9, 2012
PRAK is essential for ras-induced senescence and tumor suppression
Peiqing Sun1, Naoto Yoshizuka, Liguo New
1Department of Molecular Biology, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, CA 92037, USA. pqsun@scripps.edu
Abstract:
Like apoptosis, oncogene-induced senescence is a barrier to tumor development. However, relatively little is known about the signaling pathways mediating the senescence response. p38-regulated/activated protein kinase (PRAK) is a p38 MAPK substrate whose physiological functions are poorly understood. Here we describe a role for PRAK in tumor suppression by demonstrating that PRAK mediates senescence upon activation by p38 in response to oncogenic ras. PRAK deficiency in mice enhances DMBA-induced skin carcinogenesis, coinciding with compromised senescence induction. In primary cells, inactivation of PRAK prevents senescence and promotes oncogenic transformation. Furthermore, we show that PRAK activates p53 by direct phosphorylation. We propose that phosphorylation of p53 by PRAK following activation of p38 MAPK by ras plays an important role in ras-induced senescence and tumor suppression.
Insights
Oncogene-induced senescence, a tumor suppressor, is mediated by p38-regulated/activated protein kinase (PRAK). PRAK activation by p38 in response to oncogenic ras promotes senescence, inhibiting tumor development.
Area of Science:
- Molecular Biology
- Cellular Biology
- Cancer Research
Background:
- Oncogene-induced senescence is a critical tumor suppressive mechanism, similar to apoptosis.
- The specific signaling pathways that mediate senescence are not fully understood.
- p38-regulated/activated protein kinase (PRAK), a substrate of p38 MAPK, has poorly defined physiological roles.
Purpose of the Study:
- To elucidate the role of PRAK in tumor suppression.
- To investigate the involvement of PRAK in oncogene-induced senescence.
- To identify the downstream targets and mechanisms of PRAK signaling in senescence.
Main Methods:
- Utilized mouse models of skin carcinogenesis (DMBA-induced).
- Investigated PRAK function in primary cells and its role in oncogenic transformation.
- Examined the direct interaction and phosphorylation of p53 by PRAK in vitro and in vivo.
Main Results:
- PRAK deficiency in mice led to increased skin carcinogenesis and impaired senescence induction.
- Inactivation of PRAK in primary cells abrogated senescence and promoted oncogenic transformation.
- PRAK was demonstrated to directly phosphorylate and activate p53.
Conclusions:
- PRAK acts as a mediator of oncogene-induced senescence upon activation by p38 MAPK.
- PRAK plays a significant role in tumor suppression by promoting senescence.
- The PRAK-p53 axis is a key pathway in ras-induced senescence and tumor suppression.
More Related Videos
13:59A Quantitative Measurement of Reactive Oxygen Species and Senescence-associated Secretory Phenotype in Normal Human Fibroblasts During Oncogene-induced Senescence
Published on: August 12, 2018
08:12Identification of EGFR and RAS Inhibitors using Caenorhabditis elegans
Published on: October 5, 2020
Related Concept Videos
Replicative Cell Senescence
Abnormal Proliferation
The Ras Gene
Ras is a superfamily...
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Replicative Cell Senescence
The Ras Gene
Ras is a superfamily...